Amylyx Pharmaceuticals' (AMLX) Relyvrio Receives Approval from FDA
Go back to Amylyx Pharmaceuticals' (AMLX) Relyvrio Receives Approval from FDA| (NASDAQ: AMLX) | Delayed: 16.28 +0.61 (3.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.67 | 52 Week High | $ | |||
| Open | $15.91 | 52 Week Low | $ | |||
| Day High | $16.38 | P/E | N/A | |||
| Day Low | $15.73 | EPS | $ | |||
| Volume | 1,353,201 | |||||
